Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aliasgar Moiyadi

Showing results (81-90 of 161) with videos related to

Pageof 17
Sort By:
Neuro-Oncology Practice|May 23, 2022
Neurocognitive function and survival in children with average-risk medulloblastoma treated with hyperfractionated radiation therapy alone: Long-term mature outcomes of a prospective studyTejpal Gupta, Babusha Kalra, Savita Goswami, et al.
Neurology India|September 11, 2021
Biomarkers of Systemic Inflammation in Patients with Glioblastoma: An Analysis of Correlation with Tumour-Related Factors and SurvivalVenkatesh S Madhugiri, Venkatesan Subeikshanan, Akshat Dutt, et al.
Journal of Cancer Research and Therapeutics|March 2, 2011
Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathwayAmit Gokhale, Ratika Kunder, Atul Goel, et al.
Nuclear Medicine Communications|September 19, 2017
Common malignant brain tumors: can 18F-FDG PET/CT aid in differentiation?Nilendu C Purandare, Ameya Puranik, Sneha Shah, et al.
World Neurosurgery|July 10, 2021
Upfront Therapy of Aggressive/High-Risk Low-Grade Glioma: Single-Institution Outcome Analysis of Temozolomide-Based Radio-Chemotherapy and Adjuvant ChemotherapySachith Anand, Abhishek Chatterjee, Tejpal Gupta, et al.
Clinical Neurology and Neurosurgery|June 4, 2015
Impact of oligodendroglial component in glioblastoma (GBM-O): Is the outcome favourable than glioblastoma?Jayant S Goda, Shirley Lewis, Aditi Agarwal, et al.
Practical Radiation Oncology|June 5, 2018
Impact of timing of radiation therapy on outcomes in atypical meningioma: A clinical auditSidharth Pant, Raees Tonse, Sadhana Kannan, et al.
Proteomics|June 12, 2012
Investigation of serum proteome alterations in human glioblastoma multiformeKishore Gollapalli, Sandipan Ray, Rajneesh Srivastava, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 28, 2020
Clinico-radiological characteristics, histo-pathological features and long-term survival outcomes in central neurocytoma: A single-institutional auditDinesh Pawar, Abhishek Chatterjee, Sridhar Epari, et al.
Nuclear Medicine Communications|January 16, 2020
Differentiating dural metastases from meningioma: role of 68Ga DOTA-NOC PET/CTNilendu C Purandare, Ameya Puranik, Sneha Shah, et al.
Pageof 17

Showing results (81-90 of 161) with videos related to

Sort By:
Pageof 17
Neuro-Oncology Practice|May 23, 2022
Neurocognitive function and survival in children with average-risk medulloblastoma treated with hyperfractionated radiation therapy alone: Long-term mature outcomes of a prospective studyTejpal Gupta, Babusha Kalra, Savita Goswami, et al.
Neurology India|September 11, 2021
Biomarkers of Systemic Inflammation in Patients with Glioblastoma: An Analysis of Correlation with Tumour-Related Factors and SurvivalVenkatesh S Madhugiri, Venkatesan Subeikshanan, Akshat Dutt, et al.
Journal of Cancer Research and Therapeutics|March 2, 2011
Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathwayAmit Gokhale, Ratika Kunder, Atul Goel, et al.
Nuclear Medicine Communications|September 19, 2017
Common malignant brain tumors: can 18F-FDG PET/CT aid in differentiation?Nilendu C Purandare, Ameya Puranik, Sneha Shah, et al.
World Neurosurgery|July 10, 2021
Upfront Therapy of Aggressive/High-Risk Low-Grade Glioma: Single-Institution Outcome Analysis of Temozolomide-Based Radio-Chemotherapy and Adjuvant ChemotherapySachith Anand, Abhishek Chatterjee, Tejpal Gupta, et al.
Clinical Neurology and Neurosurgery|June 4, 2015
Impact of oligodendroglial component in glioblastoma (GBM-O): Is the outcome favourable than glioblastoma?Jayant S Goda, Shirley Lewis, Aditi Agarwal, et al.
Practical Radiation Oncology|June 5, 2018
Impact of timing of radiation therapy on outcomes in atypical meningioma: A clinical auditSidharth Pant, Raees Tonse, Sadhana Kannan, et al.
Proteomics|June 12, 2012
Investigation of serum proteome alterations in human glioblastoma multiformeKishore Gollapalli, Sandipan Ray, Rajneesh Srivastava, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 28, 2020
Clinico-radiological characteristics, histo-pathological features and long-term survival outcomes in central neurocytoma: A single-institutional auditDinesh Pawar, Abhishek Chatterjee, Sridhar Epari, et al.
Nuclear Medicine Communications|January 16, 2020
Differentiating dural metastases from meningioma: role of 68Ga DOTA-NOC PET/CTNilendu C Purandare, Ameya Puranik, Sneha Shah, et al.
Pageof 17